Commission Approves Final Consent Order in Matter of Allergan/Inamed

Share This Page

For Your Information

Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Allergan, Inc.’s acquisition of Inamed Corporation. The vote to approve the final order was 4-0, with Commissioner J. Thomas Rosch recused. Copies are available now on the FTC’s Web site as a link to this press release. (FTC File No. 061-0031; the staff contact is James E. Southworth, Bureau of Competition, 202-326-2822.)

Copies of the documents mentioned in this release are available from the FTC’s Web site at and from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, DC 20580. Call toll-free: 1-877-FTC-HELP.

Contact Information

Media Contact:
FTC Office of Public Affairs